235 related articles for article (PubMed ID: 29928237)
1. Neuromarkers for Mental Disorders: Harnessing Population Neuroscience.
Jollans L; Whelan R
Front Psychiatry; 2018; 9():242. PubMed ID: 29928237
[TBL] [Abstract][Full Text] [Related]
2. Neuromarkers in addiction: definitions, development strategies, and recent advances.
Harp NR; Wager TD; Kober H
J Neural Transm (Vienna); 2024 May; 131(5):509-523. PubMed ID: 38630190
[TBL] [Abstract][Full Text] [Related]
3. Computational neuroscience approach to biomarkers and treatments for mental disorders.
Yahata N; Kasai K; Kawato M
Psychiatry Clin Neurosci; 2017 Apr; 71(4):215-237. PubMed ID: 28032396
[TBL] [Abstract][Full Text] [Related]
4. Leveraging Machine Learning for Gaining Neurobiological and Nosological Insights in Psychiatric Research.
Chen J; Patil KR; Yeo BTT; Eickhoff SB
Biol Psychiatry; 2023 Jan; 93(1):18-28. PubMed ID: 36307328
[TBL] [Abstract][Full Text] [Related]
5. The Clinical Added Value of Imaging: A Perspective From Outcome Prediction.
Jollans L; Whelan R
Biol Psychiatry Cogn Neurosci Neuroimaging; 2016 Sep; 1(5):423-432. PubMed ID: 29560871
[TBL] [Abstract][Full Text] [Related]
6. Data-driven approaches to neuroimaging biomarkers for neurological and psychiatric disorders: emerging approaches and examples.
Calhoun VD; Pearlson GD; Sui J
Curr Opin Neurol; 2021 Aug; 34(4):469-479. PubMed ID: 34054110
[TBL] [Abstract][Full Text] [Related]
7. Machine learning approaches for parsing comorbidity/heterogeneity in antisociality and substance use disorders: A primer.
Shane MS; Denomme WJ
Personal Neurosci; 2021; 4():e6. PubMed ID: 34909565
[TBL] [Abstract][Full Text] [Related]
8. Making Individual Prognoses in Psychiatry Using Neuroimaging and Machine Learning.
Janssen RJ; Mourão-Miranda J; Schnack HG
Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 Sep; 3(9):798-808. PubMed ID: 29789268
[TBL] [Abstract][Full Text] [Related]
9. Prediction as a humanitarian and pragmatic contribution from human cognitive neuroscience.
Gabrieli JDE; Ghosh SS; Whitfield-Gabrieli S
Neuron; 2015 Jan; 85(1):11-26. PubMed ID: 25569345
[TBL] [Abstract][Full Text] [Related]
10. Integrating genomics and neuromarkers for the era of brain-related personalized medicine.
Gordon E
Per Med; 2007 May; 4(2):201-215. PubMed ID: 29788634
[TBL] [Abstract][Full Text] [Related]
11. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
[TBL] [Abstract][Full Text] [Related]
12. The coordination dynamics of social neuromarkers.
Tognoli E; Kelso JA
Front Hum Neurosci; 2015; 9():563. PubMed ID: 26557067
[TBL] [Abstract][Full Text] [Related]
13. Psychiatric diagnosis and treatment in the 21st century: paradigm shifts versus incremental integration.
Stein DJ; Shoptaw SJ; Vigo DV; Lund C; Cuijpers P; Bantjes J; Sartorius N; Maj M
World Psychiatry; 2022 Oct; 21(3):393-414. PubMed ID: 36073709
[TBL] [Abstract][Full Text] [Related]
14. Research Domain Criteria: Cutting Edge Neuroscience or Galen's Humors Revisited?
Ross CA; Margolis RL
Mol Neuropsychiatry; 2018 Dec; 4(3):158-163. PubMed ID: 30643789
[TBL] [Abstract][Full Text] [Related]
15. A review of the neurobiological underpinning of comorbid substance use and mood disorders.
Gómez-Coronado N; Sethi R; Bortolasci CC; Arancini L; Berk M; Dodd S
J Affect Disord; 2018 Dec; 241():388-401. PubMed ID: 30145509
[TBL] [Abstract][Full Text] [Related]
16. Annual Research Review: Discovery science strategies in studies of the pathophysiology of child and adolescent psychiatric disorders--promises and limitations.
Zhao Y; Castellanos FX
J Child Psychol Psychiatry; 2016 Mar; 57(3):421-39. PubMed ID: 26732133
[TBL] [Abstract][Full Text] [Related]
17. The DSM-ICD diagnostic approach as an essential bridge between the patient and the "big data".
Mitropoulos GB
Psychiatriki; 2018; 29(3):249-256. PubMed ID: 30605429
[TBL] [Abstract][Full Text] [Related]
18. Neurobiology of Comorbid Substance Use Disorders and Psychiatric Disorders: Current State of Evidence.
Singh Balhara YP; Patnaik Kuppili P; Gupta R
J Addict Nurs; 2017; 28(1):E1-E2. PubMed ID: 28252513
[TBL] [Abstract][Full Text] [Related]
19. Biomarker identification in psychiatric disorders: from neuroscience to clinical practice.
Razafsha M; Khaku A; Azari H; Alawieh A; Behforuzi H; Fadlallah B; Kobeissy FH; Wang KK; Gold MS
J Psychiatr Pract; 2015 Jan; 21(1):37-48. PubMed ID: 25603450
[TBL] [Abstract][Full Text] [Related]
20. Should we expect "neural signatures" for DSM diagnoses?
Gillihan SJ; Parens E
J Clin Psychiatry; 2011 Oct; 72(10):1383-9. PubMed ID: 21457680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
